SCHEMBL6508250

SCHEMBL6508250

COc1ccc(-c2ccc(C#N)cc2)cc1-c1nc2cc(C#N)ccc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 1/20 0.47
MAPK10 P53779 1/20 0.44
DGAT1 O75907 1/20 0.43
SOAT1 P35610 1/20 0.43
KCNH2 Q12809 1/20 0.43
AMY1A P0DUB6 4/20 0.42
CHEK2 O96017 1/20 0.42
PKN1 Q16512 1/20 0.41
PKN2 Q16513 1/20 0.41
KIT P10721 1/20 0.41
SCN10A Q9Y5Y9 1/20 0.41
KDM1A O60341 1/20 0.40
ALOX5 P09917 1/20 0.40
EPHX2 P34913 1/20 0.40
STK10 O94804 1/20 0.39
SLK Q9H2G2 1/20 0.39
GUSB P08236 1/20 0.39
F7 P08709 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6061963 0.87 KDM1A (0.42) RHEBMAPK10DGAT1KCNH2AMY1A
SCHEMBL6513301 0.86 RHEB (0.44) RHEBMAPK10DGAT1SOAT1KCNH2
SCHEMBL10765326 0.84 MAPK10 (0.42) RHEBMAPK10AMY1APKN1PKN2
SCHEMBL10764183 0.82 MAPK10 (0.41) RHEBMAPK10AMY1ACHEK2PKN1
SCHEMBL10765448 0.82 ATR (0.44) MAPK10AMY1AF7
SCHEMBL6061845 0.81 RHEB (0.50) RHEBDGAT1SOAT1KCNH2AMY1A
SCHEMBL10748660 0.79 CDK4 (0.46) RHEBMAPK10AMY1APKN1PKN2
SCHEMBL6061802 0.77 RHEB (0.57) RHEBDGAT1SOAT1KCNH2CHEK2
SCHEMBL23540667 0.77 RHEB (0.48) RHEBDGAT1SOAT1KCNH2CHEK2
SCHEMBL10760601 0.77 MAPK10 (0.42) RHEBMAPK10AMY1ACHEK2PKN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050148646-A1 Dicationic triaryl analogs as anti-protozoan agents BOYKIN DAVID W (US) 2005-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148646-A1 Dicationic triaryl analogs as anti-protozoan agents DDT, DDC, DARS1 RHEB 412/4885MAPK10 2351/4885DGAT1 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.